Human Genetic Disorders Resulting in Systemic Selenoprotein Deficiency

Area of Science:

• Biochemistry
• Genetics
• Human Health

Background:

• Selenium is an essential trace element incorporated into selenoproteins, crucial for numerous biological functions.
• The selenocysteine (Sec) incorporation pathway involves genes like SECISBP2, SEPSECS, and TRU-TCA1-1.
• Defects in this pathway lead to systemic selenoprotein deficiency, impacting cellular defense against oxidative and endoplasmic reticulum stress.

Purpose of the Study:

• To investigate the clinical manifestations and genetic basis of selenoprotein deficiency disorders.
• To understand the diverse phenotypes associated with mutations in SECISBP2, SEPSECS, and TRU-TCA1-1.
• To highlight the role of selenoproteins in human health and disease.

Main Methods:

• Analysis of human genetic mutations in SECISBP2, SEPSECS, and TRU-TCA1-1.
• Clinical assessment of patients with systemic selenoprotein deficiency.
• Biochemical analysis of serum selenium levels and selenoprotein expression.

Main Results:

• Mutations in SEPSECS cause neurological phenotypes, including progressive cerebello-cerebral atrophy.
• SECISBP2 and TRU-TCA1-1 defects lead to hormonal imbalances (thyroid), low serum selenium, myopathy, photosensitivity, hearing loss, and increased adipose tissue.
• Antioxidant therapy shows potential in mitigating oxidative damage, but long-term efficacy requires further study.

Conclusions:

• Genetic defects in the selenocysteine incorporation pathway result in complex disorders with varied clinical presentations.
• Selenoprotein deficiency profoundly impacts multiple organ systems due to impaired antioxidant and stress defense mechanisms.
• Continued patient surveillance is crucial for uncovering novel phenotypes and understanding selenoprotein functions.